Results by Type
News Results 1-10 of 148
Food Safety Advice
News | www.johnshopkinshealthalerts.com | Sep 10, 2008
Johns Hopkins Nutrition|Weight Control Health Alert provides advice on cooking chicken and meat to prevent foodborne illness
Alexza Pharmaceuticals, Inc.'s AZ-004 Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
News | www.biospace.com | Sep 3, 2008
MOUNTAIN VIEW, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. today announced positive results from its first Phase 3 clinical trial of AZ-004 (Staccato(R) loxapine) in schizophrenic patients with acute agitation. Both the 5 mg and 10 mg doses of AZ-004 met the primary
http://www.biospace.com/news_story.aspx?StoryID=108453&full=1
Charity says using Valium as a substitute for heroin, increases overdose risk
News | www.news-medical.net | Sep 3, 2008
A drug charity in Britain says increasing numbers of drug users are turning to the tranquilliser Valium (diazepam) as a substitute for heroin. A drug charity in Britain says increasing numbers of drug users are turning to the tranquilliser Valium (diazepam) as a substitute for heroin.
Addicts turn to diazepam as a heroin alternative
News | news.scotsman.com | Sep 3, 2008
Addicts turn to diazepam as a heroin alternative - THE tranquilliser once known as "mother's little helper" is growing in popularity among drug addicts as an alternative to heroin, it was claimed today.
http://news.scotsman.com/health/Addicts-turn-to-diazepam-as.4452012.jp
The Wednesday News Blog
News | www.6minutes.com.au | Sep 3, 2008
Clare Martin has slammed the Federal Aboriginal health intervention as “a mess”, saying it was heartbreaking to see $1.
Drug users 'turning to diazepam'
News | news.bbc.co.uk | Sep 2, 2008
An increasing number of drug users are using tranquilisers to replace heroin or take with other drugs, a charity says.
Alexza's AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients
Press Release | www.prnewswire.com | Sep 2, 2008
Conference Call Scheduled for Today - Tuesday, September 2, 2008 at 5:00 p.m. Eastern Time MOUNTAIN VIEW, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc.
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/www/story/09-02-2008/0004877185&EDATE=
Alexza's AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients (PR Newswire)
News | us.rd.yahoo.com | Sep 2, 2008
Alexza's AZ-004 (Staccato(R) Loxapine) Phase 3 Trial Meets Primary Endpoint of Treating Acute Agitation in Schizophrenic Patients. - MOUNTAIN VIEW, Calif., Sept. 2 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA - News) today announced positive results from its first Phase 3
http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/prnews/080902/aqtu043.html?.v=71
SouthCoast Recovery Starts Valium® Treatment Program
News | www.prlog.org | Jun 25, 2008
SouthCoast Recovery Starts Valium® Treatment Program. California's foremost alcohol and drug rehab center announces the addition of a Valium Addiction Treatment program.
http://www.prlog.org/10083357-southcoast-recovery-starts-valium-treatment-program.html
Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients (PR Newswire)
Press Release | biz.yahoo.com | Apr 30, 2008
Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients. - MOUNTAIN VIEW, Calif., April 30 /PRNewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA - News) announced today that it has completed the enrollment in its Phase 2a
Or copy the embed script code below and paste it on your website:
Embed code:
>
